Dr. Jacques Tremblay

Professor, University Laval

Dr. Jacques P. Tremblay received a BSc (Honors) in Biochemistry from McGill University in 1970 and a PhD in Neuroscience from the University of California at San Diego in 1974. Since that time, he has been at Laval University as a postdoctoral fellow (1974-1975), Assistant Professor (1976-1981), Full Professor (since 1985) and Director of the Department of Anatomy (1987-1997). He is currently Full Professor in the Department of Molecular Medicine.

His research career has been dedicated to the development of therapies for hereditary diseases, especially on myoblast transplantation as a treatment for Duchenne muscular dystrophy. He has conducted a Phase I clinical trial of this therapy and is currently initiating a Phase I/II trial. Over the years, he has acquired experience in neurophysiology, cell culture, light and electron microscopy, immunology, molecular biology and gene therapy.  He has received the Best Researcher of the Year award presented by Muscular Dystrophy Canada (2005), the Sirius Award for Research presented by the CHUQ hospital (2005), the Henry Friesen Award presented by the Royal College of Physicians and Surgeons of Canada and the Canadian Society for Clinical Investigation (2006) and the Michel Sarrazin Award presented by Club de Recherche Clinique du Québec (2009). He is currently working on a 3 year development of a gene therapy for Friedreich ataxia and preparing a Phase I clinical trial.

He has published over 250 scientific articles and presented at 120 conferences and 444 posters on this type of research. He has trained 61 Masters students, 18 PhD students and 17 postdoctoral fellows. He has been a member of various committees of the American Society of Gene and Cell Therapy (ASGCT), Board member of the Cerebral Palsy Association, President of the Scientific Committee of Muscular Dystrophy Canada, member of a program committee of the Medical Research Council of Canada, Vice-president  of Muscular Dystrophy Association (MDA) (USA), Secretary and President of the Cell Transplant Society, President of the Quebec Gene Therapy Network, Editor of the Muscle section of the Cell Transplantation journal and Deputy Editor of the Molecular Therapy journal. He has received over $15 million in grants and research contracts.

Dr. Jacques Tremblay Grants